GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NantHealth Inc (OTCPK:NHIQ) » Definitions » EPS without NRI

NantHealth (NantHealth) EPS without NRI : $-6.87 (TTM As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is NantHealth EPS without NRI?

NantHealth's earnings per share without non-recurring items for the three months ended in Sep. 2023 was $-0.53. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2023 was $-6.87.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -1.90% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 17.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for NantHealth's EPS without NRI or its related term are showing as below:

NHIQ' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -66.3   Med: 4.45   Max: 33.5
Current: -1.9

During the past 9 years, NantHealth's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 33.50% per year. The lowest was -66.30% per year. And the median was 4.45% per year.

NHIQ's 3-Year EPS without NRI Growth Rate is ranked worse than
64.05% of 484 companies
in the Healthcare Providers & Services industry
Industry Median: 9.55 vs NHIQ: -1.90

NantHealth's EPS (Diluted) for the three months ended in Sep. 2023 was $-1.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was $-8.19.

NantHealth's EPS (Basic) for the three months ended in Sep. 2023 was $-1.00. Its EPS (Basic) for the trailing twelve months (TTM) ended in Sep. 2023 was $-8.19.


NantHealth EPS without NRI Historical Data

The historical data trend for NantHealth's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NantHealth EPS without NRI Chart

NantHealth Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EPS without NRI
Get a 7-Day Free Trial Premium Member Only -26.10 -8.32 -11.93 -7.66 -8.80

NantHealth Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.81 -3.33 -1.59 -1.42 -0.53

Competitive Comparison of NantHealth's EPS without NRI

For the Health Information Services subindustry, NantHealth's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NantHealth's PE Ratio without NRI Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NantHealth's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where NantHealth's PE Ratio without NRI falls into.



NantHealth EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-6.87

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NantHealth  (OTCPK:NHIQ) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NantHealth EPS without NRI Related Terms

Thank you for viewing the detailed overview of NantHealth's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


NantHealth (NantHealth) Business Description

Traded in Other Exchanges
N/A
Address
3000 RDU Center Drive, Suite 200, Morrisville, NC, USA, 27500
NantHealth Inc is a healthcare company that employs precision medicine and technology to give physicians, payers, and patients more information. The company develops software and hardware to collect, indexes, analyze and interpret molecular, financial, clinical, and operational data points to improve decision-making. The company provides cancer care solutions, provide solutions, and payer solutions.
Executives
Rao Haris Naseem director, 10 percent owner, officer: Chief Executive Officer C/O NANTHEALTH, INC., 760 W. FIRE TOWER RD., SUITE 107, WINTERVILLE NC 28590
Summus Holdings Llc 10 percent owner 2871 LAKE VISTA DR, SUITE 210, LEWISVILLE TX 75067
Ronald Allen Louks officer: Chief Operating Officer C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Nant Capital, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Patrick Soon-shiong director, 10 percent owner, officer: See Remarks 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Deanna L. Wise director C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD, CULVER CITY CA 90232
Bob Petrou officer: Interim CFO C/O NANTHEALTH, INC., 9920 JEFFERSON BLVD., CULVER CITY CA 90232
Mp 13 Ventures, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Cambridge Equities, Lp 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Allscripts Healthcare Solutions, Inc. 10 percent owner 222 MERCHANDISE MART PLAZA, SUITE 2024, CHICAGO IL 60654
Nantworks, Llc 10 percent owner 9922 JEFFERSON BOULEVARD, CULVER CITY CA 90232
Investment Office Kuwait 10 percent owner 15 CARTER LANE, LONDON X0 EC4V 5EY
Miller Edward D Jr director JOHNS HOPKINS, 733 NORTH BROADWAY - SUITE 100, BALTIMORE MD 21205
Kuwait Investment Authority On Behalf Of The Govt Of Kuwait 10 percent owner C/O HOMEPLACE OF AMERICA INC, 3200 POTTERY DRIVE, MYRTLE BEACH SC 29579
James Mark Burnett director 640 N. SEPULVEDA BLVD., LOS ANGELES CA 90049

NantHealth (NantHealth) Headlines

From GuruFocus

NantHealth to Present at the Cowen 42nd Annual Health Care Conference

By Business Wire Business Wire 03-07-2022